Technical Analysis for RCM - R1 RCM Inc.

Grade Last Price % Change Price Change
grade B 10.15 0.69% 0.07
RCM closed up 1.82 percent on Monday, March 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical RCM trend table...

Date Alert Name Type % Chg
Mar 18 MACD Bullish Signal Line Cross Bullish 0.69%
Mar 18 NR7 Range Contraction 0.69%
Mar 18 Stochastic Reached Overbought Strength 0.69%
Mar 18 Multiple of Ten Bullish Other 0.69%
Mar 18 Overbought Stochastic Strength 0.69%
Mar 15 Multiple of Ten Bearish Other 2.53%
Mar 15 Inside Day Range Contraction 2.53%
Mar 14 Golden Cross Bullish 2.11%
Mar 14 Multiple of Ten Bearish Other 2.11%
Mar 14 Inside Day Range Contraction 2.11%

Older signals for RCM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
R1 RCM Inc. offers financial services for the health care industries. The Company provides revenue cycle management and physician advisory services, as well as transforms and manages the commercial infrastructure of health care organizations. R1 RCM Inc., formerly known as Accretive Health, Inc., is headquartered in Chicago, Illinois.
Financial Services Revenue Cycle Management
Is RCM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 18 R1 RCM (RCM) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow
Mar 1 Market Trends Toward New Normal in Cypress Semiconductor, OUTFRONT Media, R1 RCM, Graham, CVS Health, and Tandem Diabetes Care — Emerging Consolidated Expectations, Analyst Ratings
Feb 26 R1 RCM's Turnaround Has Much Further To Run
Feb 25 R1 RCM to Present at the Cowen and Company 39th Annual Health Care Conference
Feb 22 R1 RCM, Inc. (RCM) CEO Joseph Flanagan on Q4 2018 Results - Earnings Call Transcript
Feb 22 Edited Transcript of RCM earnings conference call or presentation 22-Feb-19 12:30pm GMT
Feb 22 R1 RCM Inc. 2018 Q4 - Results - Earnings Call Slides
Feb 22 R1 RCM Inc. (RCM) Q4 2018 Earnings Conference Call Transcript
Feb 22 R1 RCM misses by $0.02, misses on revenue
Feb 22 R1 RCM Reports Fourth Quarter and Full Year 2018 Results
See more RCM news...
Indicators
Indicator Value
52 Week High 11.0
52 Week Low 6.95
Average Volume 944,635
200-Day Moving Average 8.8698
50-Day Moving Average 8.9642
20-Day Moving Average 9.727
10-Day Moving Average 9.582
Average True Range 0.3503
ADX 20.03
+DI 24.8002
-DI 17.7328
Chandelier Exit (Long, 3 ATRs ) 9.1391
Chandelier Exit (Short, 3 ATRs ) 9.8909
Upper Bollinger Band 10.3703
Lower Bollinger Band 9.0837
Percent B (%b) 0.77
BandWidth 13.2271
MACD Line 0.2365
MACD Signal Line 0.2349
MACD Histogram 0.0016
Fundamentals Value
Market Cap 1.03 Billion
Num Shares 102 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -336.00
Price-to-Sales 0.92
Price-to-Book 4.78
PEG Ratio -3.14
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.40
Resistance 3 (R3) 10.37 10.24 10.35
Resistance 2 (R2) 10.24 10.15 10.25 10.33
Resistance 1 (R1) 10.16 10.10 10.20 10.19 10.31
Pivot Point 10.02 10.02 10.04 10.04 10.02
Support 1 (S1) 9.94 9.94 9.98 9.97 9.85
Support 2 (S2) 9.81 9.89 9.82 9.83
Support 3 (S3) 9.73 9.81 9.81
Support 4 (S4) 9.76